Mannatech (NASDAQ:MTEX) Receives New Coverage from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Mannatech (NASDAQ:MTEX) in a research report released on Tuesday. The brokerage issued a buy rating on the stock.

Mannatech Stock Performance

Shares of MTEX stock opened at $7.35 on Tuesday. The company has a current ratio of 1.17, a quick ratio of 0.62 and a debt-to-equity ratio of 0.54. The stock has a 50 day simple moving average of $7.43 and a 200-day simple moving average of $7.66. The company has a market cap of $13.85 million, a price-to-earnings ratio of -8.26 and a beta of 1.17. Mannatech has a 12-month low of $6.75 and a 12-month high of $10.81.

Mannatech (NASDAQ:MTEX) last announced its quarterly earnings data on Tuesday, August 13th. The company reported ($0.33) earnings per share for the quarter. Mannatech had a negative return on equity of 11.87% and a negative net margin of 0.97%. The business had revenue of $27.74 million for the quarter.

Insider Buying and Selling

In other Mannatech news, Director Larry A. Jobe sold 16,288 shares of the stock in a transaction dated Monday, September 9th. The shares were sold at an average price of $7.75, for a total value of $126,232.00. Following the completion of the transaction, the director now directly owns 54,721 shares of the company’s stock, valued at approximately $424,087.75. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. 41.50% of the stock is owned by insiders.

About Mannatech

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.